Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00482547 · ClinicalTrials.gov registry record · Phase 4
Study of a Urethral Catheter Coated With Eluting Silver Salts (SUCCESS)
A Phase 4 study, sponsored by C. R. Bard.
- Terminated
- Registry status
- Phase 4
- Development phase
- 1,188
- Enrollment target
NCT00482547 is a Phase 4 study that was terminated before completion, run by C. R. Bard. The registered enrollment target is 1,188 participants.
The verdict
NCT00482547, a Phase 4 study, was terminated before completion, sponsored by C. R. Bard.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 1,188 participants
- Enrollment target
Study Summary
Urinary catheters are often needed in hospital patients, but their use can increase the chance that a catheter associated urinary tract infection (called a CAUTI) may occur. This study will try to determine if patients who get a new silver coated catheter will have slower to time to development of a CAUTI compared to patients who get an uncoated catheter.
Interventions
- DEVICE Hydrogel Silver Salts Coated Latex Urinary Catheter System
- DEVICE Bard silicone elastomer coated latex catheter system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,188 participants |
| Start Date | 2007-06 |
| Est. Completion | 2008-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00482547
The ClinicalTrials.gov registry entry for NCT00482547 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 1,188 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hydrogel Silver Salts Coated Latex Urinary Catheter System is the first listed.
NCT00482547 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00482547 about?
NCT00482547 is a clinical study titled "Study of a Urethral Catheter Coated With Eluting Silver Salts (SUCCESS)". Urinary catheters are often needed in hospital patients, but their use can increase the chance that a catheter associated urinary tract infection (called a CAUTI) may occur. This study will try to determine if patients who get a new silver coated catheter will have slower to time to development of a...
What is the current status of trial NCT00482547?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 1,188 participants. The study started on 2007-06. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00482547?
The interventions under investigation include: Hydrogel Silver Salts Coated Latex Urinary Catheter System (DEVICE), Bard silicone elastomer coated latex catheter system (DEVICE).
Who is sponsoring clinical trial NCT00482547?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.